Nuveen
BLFS icon

Nuveen’s BioLife Solutions BLFS Stock Holding History

Nuveen’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17M Sell
76,695
-32,487
-30% -$759K ﹤0.01% 2540
2026
Q1 		$2.08M Sell
109,182
-2,774
-2% -$61.3K ﹤0.01% 2264
2025
Q4 		$2.71M Buy
111,956
+45,113
+67% +$1.18M ﹤0.01% 2165
2025
Q3 		$1.71M Hold
66,843
– – ﹤0.01% 2362
2025
Q2 		$1.44M Sell
66,843
-469,454
-88% -$10.6M ﹤0.01% 2442
2025
Q1 		$37.2M Buy
536,297
+456,137
+569% +$12M 0.01% 757
2024
Q4 		$2.08M Hold
80,160
– – ﹤0.01% 2367
2024
Q3 		$2.01M Hold
80,160
– – ﹤0.01% 2407
2024
Q2 		$1.72M Hold
80,160
– – ﹤0.01% 2463
2024
Q1 		$1.49M Hold
80,160
– – ﹤0.01% 2526
2023
Q4 		$1.3M Buy
80,160
+602
+0.8% +$7.68K ﹤0.01% 2608
2023
Q3 		$1.1M Sell
79,558
-708
-0.9% -$11.2K ﹤0.01% 2534
2023
Q2 		$1.77M Buy
80,266
+4,445
+6% +$93.6K ﹤0.01% 2408
2023
Q1 		$1.65M Sell
75,821
-13,767
-15% -$310K ﹤0.01% 2417
2022
Q4 		$1.63M Sell
89,588
-14,293
-14% -$295K ﹤0.01% 2476
2022
Q3 		$2.36M Sell
103,881
-3,859
-4% -$82.6K ﹤0.01% 2316
2022
Q2 		$1.49M Sell
107,740
-349,458
-76% -$5.13M ﹤0.01% 2597
2022
Q1 		$10.5M Buy
457,198
+79,434
+21% +$2.09M ﹤0.01% 1614
2021
Q4 		$14.1M Buy
377,764
+77,364
+26% +$3.32M ﹤0.01% 1465
2021
Q3 		$12.7M Sell
300,400
-84,130
-22% -$4.05M ﹤0.01% 1609
2021
Q2 		$17.1M Buy
384,530
+201,711
+110% +$7.11M 0.01% 1490
2021
Q1 		$6.58M Buy
182,819
+107,252
+142% +$4.24M ﹤0.01% 2025
2020
Q4 		$3.01M Buy
75,567
+14,643
+24% +$499K ﹤0.01% 2305
2020
Q3 		$1.76M Buy
60,924
+39,964
+191% +$863K ﹤0.01% 2445
2020
Q2 		$343K Buy
+20,960
New +$289K ﹤0.01% 3014

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen's BLFS Position: Q2 2026 in Review

Nuveen reduced its BioLife Solutions (BLFS) stake by 30% in Q2 2026, selling an estimated $759K and leaving 76,695 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2540.

Nuveen first reported a position in BLFS in Q2 2020 and has held it in 25 quarters since. The position peaked at $37.2M in Q1 2025. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Nuveen held 76,695 shares of BioLife Solutions worth $2.17M as of Q2 2026.
  • Nuveen sold 32,487 BioLife Solutions shares in Q2 2026, an estimated $759K.
  • BioLife Solutions made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2540 holding.
  • Nuveen first reported a position in BioLife Solutions in Q2 2020 and has held it in 25 quarters since.
  • Nuveen's BioLife Solutions position peaked at $37.2M in Q1 2025.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.